India's Pharma Wars

The Swiss pharmaceutical giant Novartis and German drug maker Bayer are challenging the Indian establishment over the country’s drug-patent rules, an affair that frames the larger confrontation between the global pharmaceutical industry and the governments of the emerging economies.

Read →

Comments on this post are for paid subscribers